0001209191-21-037641.txt : 20210603 0001209191-21-037641.hdr.sgml : 20210603 20210603162029 ACCESSION NUMBER: 0001209191-21-037641 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210601 FILED AS OF DATE: 20210603 DATE AS OF CHANGE: 20210603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRISCOLL FREDERICK W CENTRAL INDEX KEY: 0001129890 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36287 FILM NUMBER: 21992752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Flexion Therapeutics Inc CENTRAL INDEX KEY: 0001419600 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: (781) 305-7777 MAIL ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-01 0 0001419600 Flexion Therapeutics Inc FLXN 0001129890 DRISCOLL FREDERICK W C/O FLEXION THERAPEUTICS, INC. 10 MALL ROAD, SUITE 301 BURLINGTON MA 01803 0 1 0 0 Chief Financial Officer Common Stock 2021-06-01 4 A 0 28000 0.00 A 30680 D Stock option (right to buy) 8.35 2021-06-01 4 A 0 168000 0.00 A 2031-05-31 Common Stock 168000 168000 D Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan. 25% of the shares subject to the option shall vest on the one-year anniversary of May 17, 2021 (the "Vesting Commencement Date"), and 1/48th of the shares subject to the option shall vest each month following the one-year anniversary of the Vesting Commencement Date, so that all of the shares subject to the options shall be vested four years after the Vesting Commencement Date. /s/ Mark S. Levine, Attorney-in-Fact 2021-06-03